London, ATMPS Ltd/Hataali – the leader in blockchain-based data sharing platforms for advanced therapies – announces it has been granted a patent from the United States Patent and Trademark Office (USPTO) for the use of blockchain technologies in personalised medicines. The company also has applications pending in both Europe and Asia as it looks to cement its technological advantage in the rapidly growing advanced therapy space globally. The new patent comes at a key time for the pharma industry with more than ten advanced therapies anticipated to be approved in the next year as pharma companies continue to struggle with how
The post Hataali wins US patent for the use of blockchain in advanced medicinal therapy products appeared first on Pharma Mirror Magazine.
